أعضاء هيئة التدريس | مواقع أعضاء هيئة التدريس

د.احمد عادل محمد العامر

Post graduate year residency 1 &2 in Clinical Pharmacy Fellowship in Human Therapeutics and Clinical Research أستاذ مساعد كلية الصيدلة بالخرج

الخرج
011-588-6639
aa.alamer@psau.edu.sa

السيرة الذاتية
الأبحاث العلمية

المؤهلات العلمية

Post Graduate Pharmacy Year 1 Residency (University of Arizona-USA)
Doctor of Pharmacy (PharmD) (King Faisal University)
Board Certified in Advance Diabetes Management (BC-ADM)
Fellowship in Human Therapeutics and Clinical Research (University of Arizona-USA)
Post Graduate Pharmacy Year 2 Ambulatory Care Residency (University of Arizona-USA)

الاهتمامات البحثية

Internal medicine
Clinical Pharmacy
Endocrinology
Observational studies
Diabetes management

الخبرات

3-9-2022 - حتى الآن - Assistant professor - Prince Sattam bin Abdulaziz University
23-9-2013 - 3-9-2022 - Teaching assistant - Prince Sattam bin Abdulaziz University
1-7-2017 - 1-7-2019 - Clinical Pharmacist - University of Arizona
2-1-2020 - 2-1-2022 - Postdoctoral fellow - University of Arizina of Arizona

مهام ومسؤوليات

The Committee for Strategies and Ethics of Scientific Research

الأبحاث العلمية

Hassan, E.W.E., Alamer, A., Alnami, S.S., Alhawaj, I.A., Alsmail, A.H., Alshawaf, M.A., Aljazeeri, M.A., Alghafli, M.J., Alhejji, F.Y., Alfayez, O.M. and Alharthi, M.M., 2025. DPP4 inhibitors and COVID19 outcomes in patients with type II diabetes: a multicenter retrospective cohort study in Saudi Arabia. Cardiovascular Diabetology–Endocrinology Reports, 11(1), pp.1-12. (first co-author)
Bamogaddam RF, Alamer A, Alqarni S, Almotairi MM, Almakrami AA, Alharbi AM, Alamri R, Altamimi M, Alkhulaif A, Alanazi R, Almohammed OA. Incidence and predictors of vancomycin nephrotoxicity and mortality in patients with chronic liver disease: a two-center retrospective cohort study. BMC Infectious Diseases. 2025 Mar 18;25(1):375. (first co-author)
Alamer, A., Alyazidi, W., Aldosari, S., Mobarki, F., Almakki, S., Alahmari, A., … Fazel, M. (2024). Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia. Journal of Dermatological Treatment, 35(1). https://doi.org/10.1080/09546634.2024.2386973
Alamer A, Al Lehaibi LH, Alomar M, Aldhuwayan F, Alshouish S, Al-Ali AY, Almudhry Z, Almulhim A, Althagafi A, Aldosari S, AlAmeel T. Short term effectiveness of ustekinumab versus vedolizumab in Crohn’s disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis. Saudi Journal of Gastroenterology. 2024 Sep 1;30(5):324-34.
Mohzari, Y.A., AlDosary, O.F., Bamogaddam, R.F., AlHussaini, M., Al Alyami, H., Alrashed, A. and Alamer, A., 2024. Endogenous Bacterial Endophthalmitis in an HIV Patient with Uncontrolled Diabetes: A Case of Rare Ocular Complication. Journal of Infection and Public Health.
Kurdi, S.M., Alamer, A., Alqarni, A., AlQahtani, S., AlKahlah, S., Alotaibi, F.M., Asiri, I.M. and Wali, H.A., 2024, July. Insight into Current Practices of Community Pharmacists in Topical Corticosteroid Prescribing and Counseling: Cross-Sectional Survey Study from Saudi Arabia. In Healthcare (Vol. 12, No. 14, p. 1425). MDPI.
AlGhalawin, L.S., Alomar, M., Al Bassam, S., AlHamdan, A.A., Anan, H., Altaweel, M., Alomran, Z.A., Al Khamis, R., Alqatri, A.I., Alamoudi, M.M. and Alamer, A., 2024. Incidence Rate of Cardiovascular Events in Rheumatoid Arthritis: An Observational Cohort Study in Saudi Arabia. Journal of Multidisciplinary Healthcare, pp.3357-3370. (senior author)
Almulhim, A.S., Alabdulwahed, M.A., Aldoughan, F.F., Aldayyen, …A.M, Alamer, A..et al. "Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients." Pharmaceuticals 17.5 (2024): 624.
Alshammari, M.A., Alamer, A., Al Lehaibi,., et al. "Association between COVID-19 severity and tobacco smoking status: a retrospective cohort study using propensity score matching weights analysis." BMJ Open Respiratory Research 11.1 (2024): e001976.
Al-Ali, A., Alamer, A., Alomar, M., Sharrofna, A., Abualrahi, D., Al Lehaibi, L., Alothman, A., Aldosari, S. and Alameel, T., 2024. P1020 Developing and Validating a Clinical Prediction Model Using Biomarkers to Assess Clinical Response and Severity of Crohn's Disease 12 Weeks After Initiation of Biological Therapy. Journal of Crohn's and Colitis, 18(Supplement_1), pp.i1844-i1844 (Conference publication, supervisor of the research)
Alamer, A., Al Lehaibi, L., Alomar, M., Aldhuwayan, F., Alshouish, S., Al-Ali, A., Almudhry, Z., Almulhim, A., Althagafi, A., Aldosari, S. and Alameel, T., 2024. P688 Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn’s Disease After Failure of Anti-TNF Agents: Real-World Evidence. Journal of Crohn's and Colitis, 18(Supplement_1), pp.i1307-i1307. (Conference publication)
Kurdi, S.M., Alamer, A., Albaggal, A., Alsuwaiket, M., Alotaibi, F.M., Asiri, I.M., Alshayban, D.M., Alsultan, M.M., Alshehail, B., Almalki, B.A. and Hussein, D., 2024. The Association between Self-Care Activities and Depression in Adult Patients with Type 2 Diabetes in Saudi Arabia: A Cross-Sectional Web-Based Survey Study. Journal of Clinical Medicine, 13(2), p.419 (First co-author)
Almalki ZS, Imam MT, Ahmed NJ, Ghanem RK, Alanazi TS, Juweria S, Alanazi TS, Alqadhibi RB, Alsaleh S, Hasino FH, saad Alsffar A,, Alamer A. The Influence of Telemedicine in Primary Healthcare on Diabetes Mellitus Control and Treatment Adherence in Riyadh Region. Saudi Pharmaceutical Journal. 2023 Dec 13:101920.
Almalki, Z.S., Imam, M.T., Abou Chahin, N.F., ALSammak, N.S., Entabli, S.M., Alhammad, S.K., Alanazi, G.F., Kharsa, R.A., Alonazi, L.A., Mandil, R.A. and Albassam, A.A… Alamer A, 2023. Access and Disparities in the Use of Telemedicine Among Patients with Chronic Conditions in Saudi Arabia: A Cross-Sectional Study. Journal of Multidisciplinary Healthcare, pp.3789-3798.
Ahmed NJ, Almalki ZS, Alsawadi AH, Alturki AA, Bakarman AH, Almuaddi AM, Alshahrani SM, Alanazi MB, Alshehri AM, Albassam AA, Fatani S…. Alamer A. Knowledge, perceptions, and readiness of telepharmacy among community pharmacists. Saudi Pharmaceutical Journal. 2023 Sep 1;31(9):101713.
Ahmed NJ, Almalki ZS, Alsawadi AH, Alturki AA, Bakarman AH, Almuaddi AM, Alshahrani SM, Alanazi MB, Alshehri AM, Albassam AA, Alahmari AK… Alamer A. Knowledge, Perceptions, and Readiness of Telepharmacy among Hospital Pharmacists in Saudi Arabia. InHealthcare 2023 Apr 11 (Vol. 11, No. 8, p. 1087). MDPI.
Mohzari YA, Musawa MA, Alrashed A, Zaeri B, Damfu N, Cahusac P, Alwafai S, Alamer A, Almulhim A. The Clinical Impact of Rifampicin-Based Anti-TB Therapy and Tenofovir Alafenamide-Containing ARV Regimen Drug. Interaction¸ in People Living with HIV: Case Series Report. Journal of Infection and Public Health. 2023 Oct 7.
Cameron C, Carroll K, Forbes A, Luca X, Alamer A, Fazel MT. A Cross-Sectional Survey Study of Student Pharmacists’ Career Interests. Journal of Pharmacy Practice. 2023 Sep 1:08971900231198926.
Kurdi S, Alamer A, Wali H, Badr AF, Pendergrass ML, Ahmed N, Abraham I, Fazel MT. Proof-of-concept Study of Using Supervised Machine Learning Algorithms to Predict Self-care and Glycemic Control in Type 1 Diabetes Patients on Insulin Pump Therapy. Endocrine Practice. 2023 Mar 8. (First co-author)
Alowais SA, Wali HA, Tabb D, Alamer A, Ahmed N, Baloch SA, Floyd JC. Assessing tobramycin levels and renal function following the implantation of CaSO4 beads impregnated with tobramycin: A prospective cohort study. Medicine. 2022 Dec 9;101(49):e32276.
Bamogaddam RF, Mohzari Y, Aldosari FM, Alrashed AA, Almulhim AS, Kurdi S, Alohaydib MH, Alotaibi OM, Alotaibi AZ, Alamer A. Prevalence and Associations of Type 2 Diabetes Risk and Sociodemographic Factors in Saudi Arabia: A Web-Based Cross-Sectional Survey Study. International Journal of Environmental Research and Public Health. 2023 Jan 27;20(3):2269. *Senior author
Alamer A, Almutairi AR, Halloush S, Al-Jedai A, Alrashed A, AlFaifi M, Mohzari Y, Almutairi M, AlHassar F, Howaidi J, Almutairi W. Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi Arabian pandemic referral hospitals. Saudi Pharmaceutical Journal. 2023 Feb 15.
Aldayyen AM, Alwabari MA, Alhaddad F, Alhumaid MA, Alsuwailem N, Alanzi A, Alalwan AA, Alfayez O, Alwafai S, Aldosari SA, Ahmed NJ, Almalki Z, Alamer A. Types, trends, and patterns of the reported antimicrobial errors to the eastern region’s medical centers in Saudi Arabia: A cross-sectional study. Saudi Pharmaceutical Journal. 2023 Apr 1;31(4):569-77. *Senior author
Tran JS, Loveland MG, Alamer A, Piña IL, Sweitzer NK. Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction. Circulation: Heart Failure. 2022 Nov;15(11):e009395.
Ahmed NJ, Haseeb A, Alamer A, Almalki ZS, Alahmari AK, Khan AH. Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention. Antibiotics. 2022 Nov 3;11(11):1543.
AlLehaibi LH, Alomar M, Almulhim A, Al-Makki S, Alrwaili NR, Al-Bassam S, Alsultan S, Al Saeed J, Alsheef M, Abraham I, Alamer A. Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence. Annals of Pharmacotherapy. 2022 Aug 8:10600280221115299. *Senior author
Ahmed NJ, Haseeb A, Alamer A, Almalki ZS, Alahmari AK, Khan AH. Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention. Antibiotics. 2022 Nov 3;11(11):1543
Alosaimi B, Alshanbari HM, Alturaiqy M, AlRawi HZ, Alamri S, Albujaidy A, Bin Sabaan A, Alrashed AA, Alamer A, Alghofaili F, Al-Duraymih K. Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals. 2022 Dec;15(12):1456.
Choi BM, Aqel O, Abraham RB, Obeng-Kusi M, Calamia M, Halawah H, Alamer A, McBride A, Abraham I, Tugay D. Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 2 disease. Journal of Clinical Oncology 2022 40:16_suppl, e20502-e20502
Ahmed NJ, Alshehri AM, Almalki ZS, Alamer A, Albassam AA, Alahamri AK, Alonazi K, Abdelkader MS. Cross-sectional Study on Using Herbal Products and Medications During the COVID-19 Pandemic. LATIN AMERICAN JOURNAL OF PHARMACY. 2022 Jan 1;41(11).
Ahmed N, Alamer A, Almalki Z, Alshehri A, Alahmari A. A Descriptive Study of Drug-induced Clostridium difficile. LATIN AMERICAN JOURNAL OF PHARMACY. 2022 Jan 1;41(11).
Choi BM, Aqel O, Abraham RB, Obeng-Kusi M, Calamia M, Halawah H, Alamer A, McBride A, Abraham I, Tugay D. Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 3A disease. Journal of Clinical Oncology 2022 40:16_suppl, e20502-e20502
Choi BM, Aqel O, Abraham RB, Obeng-Kusi M, Calamia M, Halawah H, Alamer A, McBride A, Abraham I, Tugay D. Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 1B disease. Journal of Clinical Oncology 2022 40:16_suppl, e20502-e20502
Axon DR, Alamer A, Almatruk Z, Fazel MT. Assessing student pharmacists' confidence and knowledge of basic diabetes self-management skills. Currents in Pharmacy Teaching and Learning. 2022 Aug 1;14(8):982-9.
Althagafi A, Alshibani M, Alshehri SO, Barahim A, Alghamdi H, Alaslani D, Qari A, Almulhim A, Alamer A. The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest Design Study. Cureus. 2022, 1;14(12). *Senior author
Bamogaddam R, Mohzari Y, Aldosari F, Alrashed A, Almulhim A, Kurdi S, Alamer A. EPH54 Prevalence and Association of Sociodemographic Determinants With the Risk of Developing Type 2 Diabetes in Saudi Arabia: A Web-Based Cross-Sectional Survey Study. Value in Health. 2022, 1;25(12):S201. *Senior author
Mohzari Y, Musawa MA, Alrashed A, Alamer A, Almulhim AS. 1281. Rifampicin and Tenofovir Alafenamide Containing Regimen Drug Interaction in People Living with HIV: Case Series Report. InOpen Forum Infectious Diseases 2022, (Vol. 9, No. Supplement_2, pp. ofac492-1112). US: Oxford University Press.
Alrashed A, Cahusac P, Mohzari YA, Bamogaddam RF, Alfaifi M, Mathew M, Alrumayyan BF, Alqahtani BF, Alshammari A, AlNekhilan K, Binrokan A…, Alamer A. comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data. Frontiers in Cardiovascular Medicine. 2022 Aug 16:2119. *Senior author
Mohzari YA, Alamer A, Alattas M, et al. Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence. Expert Review of Anti-infective Therapy. 2022 (first co-author)
Mohzari Y, Alattas M, Almusawa M… Abraham I & Alamer A. Tocilizumab Effectiveness in Mechanically Ventilated COVID-19 Patients: A Multicenter Retrospective Study Using Propensity Score-Based Methods. JACCP Journal of the American College of Clinical Pharmacy. Published online 2021:1633-1634.
Mohzari YA, Alshuraim R, Asdaq SMB… Abraham I & Alamer A. Early oral switch to combined cefixime therapy for management of osteoarticular infections in pediatric sickle cell disease patients: A descriptive analysis. J Infect Public Health. 2022;15(1):1-6
Alajlan SA, Alhusseini NK, Asdaq SMB, Mohzari Y, Alamer A et al. The impact of lockdown strategies on the basic reproductive number of coronavirus (COVID-19) cases in Saudi Arabia. Saudi Journal of Biological Sciences. 2021;28(9):4926-4930.
Alamer A, Alrashed AA, Alfaifi M, et al. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin. 2021;37(7):1085-1097.
Alrashed AA, Khan TM, Alhusseini NK… Abraham I & Alamer A. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health. 2021;14(6):726-733. *Senior author
Cameron CK, Alamer AA, Fossati E, et al. A Survey of Arizona Pharmacists to Identify Opportunities to Enhance Pharmacists’ Competitiveness in a Tightening Labor Market. Journal of Pharmacy Practice. Published online 2021:08971900211000708.
Mohzari Y, Aljobair F, Alrashed A… Alamer A et al. Safety and efficacy of daptomycin in neonates with coagulase-negative Staphylococci: case series analysis. Antibiotics. 2021;10(2):168.
Alamer A, Te C, Fazel M. Comment on Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report. E-comment. Ann. Intern. Med 2020. https://www.acpjournals.org/doi/10.7326/L20-0549
Alamer A, Abraham I. Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the mehra et al. retraction. Pharmacol Res. 2020;160:105053.
Alamer A, Palm C, Almulhim AS, Te C, Pendergrass ML, Fazel MT. Impact of Non-Tailored One-Way Automated Short Messaging Service (OASMS) on Glycemic Control in Type 2 Diabetes: A Retrospective Feasibility Study. Int J Environ Res Public Health 2020 Oct 19;17(20):7590. doi: 10.3390/ijerph17207590
Fazel M, AlRawashdh N, Alamer A, Curiel-Lewandrowski C, Abraham I. Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma. Expert Opin Biol Ther. 2021;21(12):1647-1653.
Alamer AA, Almulhim AS, Alrashed AA, Abraham I. Mortality, severity, and hospital admission among COVID-19 patients with ACEI/ARB use: a meta-analysis stratifying countries based on response to the first wave of the pandemic. In: Healthcare. Vol 9. Multidisciplinary Digital Publishing Institute; 2021:127.
Alrashed AA, Khan TM, Alhusseini NK.. Abraham I & Alamer A. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J Infect Public Health. 2021;14(6):726-733.
Hincapie AL, Alamer A, Sears J, Warholak TL, Goins S, Weinstein SD. A quantitative and qualitative analysis of electronic prescribing incidents reported by community pharmacists. Appl Clin Inform. 2019;10(3):387-394
Almulhim AS, Alamer A. The prevalence of resistant gram-negative bacteraemia among hospitalized patients in Tucson, Arizona over a 12-month period; A retrospective single centre study. J Int Med Res. 2019:300060519829987
Alamer AA, Patanwala AE, Aldayyen AM, Fazel MT. Validation and comparison of two 30-day readmission prediction models in patients with diabetes. Endocr Pract. 2019.
Asdaq SMB, Alajlan SA, Mohzari Y, Asad M, Alamer A, Alrashed AA, Nayeem N, Nagaraja S. COVID-19 and Psychological Health of Female Saudi Arabian Population: A Cross-Sectional Study. Healthcare. 2020; 8(4):542.
POSTER PRESENTATIONS
International
Al-Ali, A., Alamer, A., Alomar, M., Sharrofna, A., Abualrahi, D., Al Lehaibi, L., Alothman, A., Aldosari, S., & Alameel, T. (2024). P1020 Developing and Validating a Clinical Prediction Model Using Biomarkers to Assess Clinical Response and Severity of Crohn's Disease 12 Weeks After Initiation of Biological Therapy. Journal of Crohn's and Colitis, 18(Supplement_1), i1844-i1844. (Conference publication, supervisor of the research) Presented at the 19th Congress of ECCO - Inflammatory Bowel Diseases 2024, February 21-24, 2024, Stockholm, Sweden.
Alamer, A., Al Lehaibi, L., Alomar, M., Aldhuwayan, F., Alshouish, S., Al-Ali, A., Almudhry, Z., Almulhim, A., Althagafi, A., Aldosari, S., & Alameel, T. (2024). P688 Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn’s Disease After Failure of Anti-TNF Agents: Real-World Evidence. Journal of Crohn's and Colitis, 18(Supplement_1), i1307-i1307. (Conference publication) Presented at the 19th Congress of ECCO - Inflammatory Bowel Diseases 2024, February 21-24, 2024, Stockholm, Sweden.
Alshreef M, Basharaheel A, Alamer A. Weaning Effect of Clonidine in Critically Ill Patients Received Dexmedetomidine at a Tertiary Hospital in Riyadh City: A Retrospective Study. In2023 ACCP Virtual Poster Symposium (May 23 and 24) 2023 May 23. American College of Clinical Pharmacy.
Aldayyen A , Alwabari M, Alhaddad F , Alhumaid M, Alsuwailem N, Alanzi A, Alalwan A, Alfayez O , Alwafai S, Aldosari S, Ahmed N , Almalki Z , Alamer A. Trends and Patterns of the Reported Antimicrobial Errors to the Eastern Region’s Medical Centers in Saudi Arabia: A Cross-Sectional Study. Poster presentation at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), ISPE, Halifax, Canada. August 2023
Bamogaddam R, Mohzari Y, Aldosari F, Alrashed A, Almulhim A, Kurdi S, Alamer A. EPH54 Prevalence and Association of Sociodemographic Determinants With the Risk of Developing Type 2 Diabetes in Saudi Arabia: A Web-Based Cross-Sectional Survey Study. Poster presented at ISPOR Europe 2022 (11 to 15 November 2023). Vienna, Austria.
Mohzari Y, Musawa MA, Alrashed A, Alamer A, Almulhim AS. 1281. Rifampicin and Tenofovir Alafenamide Containing Regimen Drug Interaction in People Living with HIV: Case Series Report. Poster at IDWEEK meeting (9-23 October 2022), Washington, DC
Fazel, M. T., Alamer, A. A., & Cameron, C. K. (2022, July).
An Innovative Approach to Keep Your Practice Site Up-to-date On Clinical Queries: The MaryamWatch Model . In ACCP Virtual Poster Symposium, 5, 729–786
Thakrar, S., Guzman, Y., Alamer, A. A., Cameron, C. K., & Fazel, M. T. (2022, July). Evaluating Availability of Glucose Data During In-person versus Telemedicine Visits in an Endocrinology Clinic . In ACCP Virtual Poster Symposium, 5, 729-786.
Axon, D. R., Alamer, A. A., & Fazel, M. T. (2021, July). Assessing Confidence and Knowledge of Student Pharmacists’ Basic Diabetes Self-Management Skills. In Research and Education Poster Abstracts Presented at the 122nd Virtual Annual Meeting of the American Association of Colleges of Pharmacy, July 19-22, 2021.American Journal of Pharmaceutical Education 2021; 85 (7) Article 8737., 85, 708.
Alamer A, Palm C, Almulhim AS, Te C, Pendergrass ML, Fazel MT. Impact of Non-Tailored One-Way Automated Short Messaging Service (OASMS) on Glycemic Control in Type 2 Diabetes: A Retrospective Feasibility Study. Poster presented at: 2020 American College of Pharmacy (ACCP) VIRTUAL Annual Meeting (October 19-30)
Mohzari Y, Alattas M, Almusawa M… Abraham I & Alamer A. Tocilizumab Effectiveness in Mechanically Ventilated COVID-19 Patients: A Multicenter Retrospective Study Using Propensity Score-Based Methods. JACCP Journal of the American College of Clinical Pharmacy 2021 j(Virtual), USA.
Blomquist K, Sims J, Stratton M, Alamer A, Fazel M. Assessing the optimal timeline for type 2 diabetes patients to achieve glycemic goal when receiving endocrinology specialty care in an ambulatory setting. ASHP 2020 Midyear; December 8, 2020 (Virtual), USA.
Fazel M, Alqifari S, Alamer A, Pendergrass M. Impact of MiniMedTM 670G Hybrid Closed-Loop (HCL) System on Glycemic Control; A Retrospective Single Center Study. Poster presented at: American Association of Colleges of Pharmacy; July 13-17, 2019; Chicago, Illinois, USA.
Fazel M, Patanwala A, Aldayyen A, Fazel M. External validation and comparison of two 30- day readmission prediction models in patients with diabetes. Poster presented at: American College of Pharmacy (ACCP) 2018 Global Conference on Clinical Pharmacy; October 23, 2018; Washington Convention Center, Seattle, Washington, USA.
Alamer A, Patanwala A, Aldayyen A, Fazel M. External validation and comparison of two 30- day readmission prediction models in patients with diabetes. Poster presented at: American College of Pharmacy (ACCP) 2018Global Conference on Clinical Pharmacy; October 23, 2018; Washington Convention Center, Seattle, Washington, USA.
Alamer A, Hincapie A, Sears J, Warholak T. Quantitative Analysis of Electronic Prescribing Quality Related-Incidents. Poster presented at: American Society of Health-System Pharmacists (ASHP) 2016 Midyear; December 6, 2016; Mandalay Bay, Convention Center, Las Vegas, Nevada, USA.
Alamer A, Zaitoun M. Safety of Herbal Products in Pregnancy: Experience from Saudi Market. Poster presented at: Dubai International Pharmaceutics And Technologies Conference and Exhibition (DUPHAT); March 12, 2013; Dubai International Convention and Exhibition Center, Dubai, United Arab Emirates.
Local
Al-Ali, A., Alamer, A., Alomar, M., Sharrofna, A., Abualrahi, D., Al Lehaibi, L., Alothman, A., Aldosari, S., & Alameel, T. (2024). P1020 Developing and Validating a Clinical Prediction Model Using Biomarkers to Assess Clinical Response and Severity of Crohn's Disease 12 Weeks After Initiation of Biological Therapy. Presented at The Saudi Digestive Diseases Forum (SDDF 2023), The Saudi Society of Gastroenterology, Jeddah, Saudi Arabia
Alamer, A., Al Lehaibi, L., Alomar, M., Aldhuwayan, F., Alshouish, S., Al-Ali, A., Almudhry, Z., Almulhim, A., Althagafi, A., Aldosari, S., & Alameel, T. (2024). P688 Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn’s Disease After Failure of Anti-TNF Agents. Retrospettive observational study. Presented at The Saudi Digestive Diseases Forum (SDDF 2023), The Saudi Society of Gastroenterology, Jeddah, Saudi Arabia
Zaitoun M, Alamer A. Safety of Herbal Products in Pregnancy and Lactation: A Cross-Sectional Market Study. Poster presented at: The Second Scientific Meeting on Medication Safety; February 26, 2013; Alfaisaliah Hotel, Riyadh, Saudi Arabia.
Alfaifi M, Alrashed AA & Alamer A. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: A pgramatic trial. June 202, Riyadh, Saudi Arabia
Alrashed A, Almulhim & A Alamer. Which Thromboprophylaxis Dose Gives the Best Clinical Outcomes? A Retrospective Cohort Study among COVID-19-Infected Critically Ill Patients; 13th Annual Research Day Student Poster Competition. March 2022, Alfaisal University, Riyadh, Saudi Arabia.
GRANTS
Saudi National Institute of Health (SNIH) fund number 35588945. for a research titled “ Short Term Effectiveness of Ustekinumab Versus Vedolizumab in Crohn Disease After Failure of Anti-TNF Agents: An Observational Study Design with a Bayesian Analysis”
King Abdul-Aziz City for Science and Technology Research Project No.5-21-01-001-0015 for a research title.“The Association Between Smoking and COVID-19 Severity: An Observational Cohort Study of Patients in a Saudi Arabian COVID-19 Center with a Matching Weights Design “
Deanship of Scientific Research at King Faisal University Grant (GRANT3,584) for a research titled “The clinical impact of rifampicin-based anti-TB therapy and tenofovir alafenamide-containing ARV regimen drug Interaction in people living with HIV: Case series report”
AWARDS/HONORS
2025 2nd place in the poster competition for students. Research day at prince sattam bin Abdulaziz university (supervisor of the research project)
2025 2nd place in the poster competition. Pharmaceutical Research and Innovation Poster Competition – King Saud University (supervisor of the research project)
2024 Best Pharmacy Practice Poster Award at College of Pharmacy, Imam Bin Abdulrahman University, students graduate research (supervisor of the research). Research entitled Cluster Analysis of Clinician’s Attitude and Perspective toward Diabetic technologies Use in Patients with Diabetes; A cross sectional study from Saudi Arabia.
2024 Second highest score in poster competition at 6th annual Arab International Pharmacy Congress (Primary Author and of the research) presented by Fahad Aldhuwayan
2023 Second Award for research poster at the Saudi Gastroenterology Association Saudi Digestive Disease Forum (SDDF 2023). Hilton, Jeddah, Saudi Arabia. (Primary Author of the research)
2022 Best research paper at the Saudi Society of Clinical Pharmacy 2023. Crowne Plaza Riyadh RDC Hotel & Convention, Riyadh, Saudi Arabia. (Supervisor of the research)
2022 Best research presentation award at IHOPE conference in healthcare practioner category. Riyadh, Saudi Arabia. (Supervisor of the research)
2022 First place at 13th Annual Research Day Student Poster Competition. Alfaisal University, Riyadh, Saudi Arabia. (Supervisor of the research)
2020 Top 10 research poster by the American College of Clinical Pharmacy Internal Medicine PRN group
Jun 2013 First Class Honor
Mar 2013 Third Place for Best Thematic Poster Presentation at International Pharmaceutics and Technologies Conference and Exhibition (DUPHAT)

موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية

روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ edu.sa

المواقع الالكترونية الحكومية تستخدم بروتوكول HTTPS للتشفير و الأمان.

مواقع أعضاء هيئة التدريس

د.احمد عادل محمد العامر

المؤهلات العلمية

الاهتمامات البحثية

الخبرات

مهام ومسؤوليات

الأبحاث العلمية

تواصل مع قيادات الجامعة

إدارة العلاقات العامة والإعلام

Social

موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية

روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ edu.sa

المواقع الالكترونية الحكومية تستخدم بروتوكول HTTPS للتشفير و الأمان.

مواقع أعضاء هيئة التدريس

د.احمد عادل محمد العامر

المؤهلات العلمية

الاهتمامات البحثية

الخبرات

مهام ومسؤوليات

الأبحاث العلمية

إدارة العلاقات العامة والإعلام